PHARMACEUTICAL COMPOSITION BASED ON 5-PENTYLRESORCINOL WITH HYPOGLYCEMIC EFFECT AND BODY WEIGHT REDUCTION EFFECT
2023-08-29
专利权人FEDERAL STATE BUDGETARY INST (FSBI-C)
申请日期2023-08-29
专利号RU2829635-C1
成果简介NOVELTY - Invention relates to a method of treating and/or preventing obesity and type II diabetes mellitus. Method of treating and/or preventing obesity and type II diabetes mellitus, involving chronic oral administration of a pharmaceutical composition containing 5-pentylresorcinol in dose of 100 mg/kg of 5-pentylresorcinol. USE - Pharmaceutical industry. ADVANTAGE - Use of the invention provides a high degree of effectiveness in reducing blood glucose and body weight in alimentary obesity and type II diabetes. 1 cl, 11 dwg, 5 tbl, 2 ex
IPC 分类号A61K-031/05 ; A61P-003/04 ; A61P-003/10
国家俄罗斯
专业领域化学化工
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/20627
专题中国科学院新疆生态与地理研究所
作者单位
FEDERAL STATE BUDGETARY INST (FSBI-C)
推荐引用方式
GB/T 7714
YUDIN S M,MAKAROV V V,SHESTOPALOV A V,et al. PHARMACEUTICAL COMPOSITION BASED ON 5-PENTYLRESORCINOL WITH HYPOGLYCEMIC EFFECT AND BODY WEIGHT REDUCTION EFFECT. RU2829635-C1[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。